Trexquant Investment’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,904
Closed -$2.47M 1874
2024
Q1
$2.47M Buy
5,904
+1,936
+49% +$809K 0.05% 574
2023
Q4
$1.61M Buy
3,968
+2,449
+161% +$996K 0.04% 632
2023
Q3
$528K Buy
+1,519
New +$528K 0.01% 990
2023
Q2
Sell
-4,176
Closed -$1.32M 1839
2023
Q1
$1.32M Sell
4,176
-48,044
-92% -$15.1M 0.04% 620
2022
Q4
$15.1M Buy
52,220
+23,040
+79% +$6.65M 0.43% 34
2022
Q3
$8.45M Buy
+29,180
New +$8.45M 0.3% 76
2021
Q4
Sell
-15,061
Closed -$2.73M 1651
2021
Q3
$2.73M Buy
+15,061
New +$2.73M 0.22% 121
2020
Q4
Sell
-18,712
Closed -$5.09M 1526
2020
Q3
$5.09M Buy
18,712
+8,206
+78% +$2.23M 0.33% 62
2020
Q2
$3.05M Sell
10,506
-3,851
-27% -$1.12M 0.21% 125
2020
Q1
$3.42M Sell
14,357
-13,134
-48% -$3.13M 0.25% 97
2019
Q4
$6.02M Buy
27,491
+9,262
+51% +$2.03M 0.36% 73
2019
Q3
$3.09M Buy
18,229
+9,027
+98% +$1.53M 0.27% 112
2019
Q2
$1.69M Sell
9,202
-14,745
-62% -$2.7M 0.15% 199
2019
Q1
$4.41M Buy
+23,947
New +$4.41M 0.31% 78
2018
Q4
Sell
-6,646
Closed -$1.28M 1330
2018
Q3
$1.28M Sell
6,646
-22,733
-77% -$4.38M 0.1% 290
2018
Q2
$4.99M Buy
29,379
+5,101
+21% +$867K 0.35% 70
2018
Q1
$3.96M Buy
+24,278
New +$3.96M 0.28% 82
2017
Q4
Sell
-5,664
Closed -$861K 1276
2017
Q3
$861K Buy
5,664
+3,354
+145% +$510K 0.22% 110
2017
Q2
$298K Sell
2,310
-14,290
-86% -$1.84M 0.08% 474
2017
Q1
$1.82M Buy
16,600
+13,100
+374% +$1.43M 0.23% 74
2016
Q4
$258K Buy
+3,500
New +$258K 0.04% 711
2016
Q2
Sell
-11,500
Closed -$914K 1128
2016
Q1
$914K Sell
11,500
-6,300
-35% -$501K 0.11% 323
2015
Q4
$2.24M Buy
+17,800
New +$2.24M 0.2% 131
2015
Q3
Sell
-20,000
Closed -$2.47M 1277
2015
Q2
$2.47M Buy
20,000
+14,000
+233% +$1.73M 0.28% 41
2015
Q1
$707K Buy
+6,000
New +$707K 0.07% 538